CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma March 25, 2022March 25, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Roche’s Polivy combination approved by European…FDA accepts supplemental Biologics License…FDA Advisory Committee votes in favour of the…Roche presents new and updated data for Polivy in…Roche’s Polivy combination reduced the risk of…CHMP recommends EU conditional approval of Roche’s…
